The government shutdown could soon jeopardize highly anticipated new drugs from Janssen, Sanofi and Novartis for depression, diabetes and multiple sclerosis, as well as a host of other potential new therapies, according to a STAT analysis of upcoming regulatory decision dates

Quick Read

Regulators had accused Mutual of Omaha of denying policies to applicants, mostly gay men, who took medication to protect against the infection

Quick Read

Portland State University has started disciplinary proceedings against Peter Boghossian, an assistant professor of philosophy who co-authored a series of bogus research papers that parody what the authors dismiss as “grievance studies.”

Quick Read

The FDA said that it had also written to 20 clinics that offer unapproved stem cell treatments, warning them that such products are generally regulated by the agency and encouraging the clinics to contact federal regulators before November 2020, when enforcement will tighten

Quick Read

The happy household of a onetime tabloid curiosity – with comments from our Jeffrey Kahn

Quick Read

News of a reckless experiment demonstrates the dangers. A response from the editorial board of Bloomberg News

Quick Read

How do you stop a mad scientist? We’ve been doing it in fiction for centuries…

Quick Read

Be the first to like. Like Unlike 0

Quick Read